ASAyesha Sherzai

Ayesha Sherzai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ayesha Sherzai has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Lifestyle Medicine for Primary and Secondary Stroke Prevention: A Narrative Review

    by Rikka Yzzabelle Tagayuna, Charis Rowden, Dean Sherzai, Ayesha Z. Sherzai

    Stroke is a leading cause of mortality and disability, affecting approximately 13.7 million individuals globally each year. It is broadly classified as ischemic or hemorrhagic and often results in cognitive, motor, and emotional impairments. Lifestyle interventions are associated with lower stroke risk and recurrent events, and are core to guideline-based prevention; effect sizes vary by risk factor, adherence, and setting. This review begins with the pathophysiology of stroke, focusing on the roles of sex hormones, genetics, environment, and lifestyle. We then outline how lifestyle interventions can aid in primary and secondary prevention of stroke by targeting modifiable risk factors responsible for approximately 90% of stroke risk, including hypertension, diabetes, high cholesterol, poor diet, sedentary behavior, abdominal obesity, psychological stress, smoking, cardiac causes, and alcohol use. We also discuss clinical implementation, policy strategies, health equity, cost-effectiveness, and future directions. These insights highlight the critical role of lifestyle medicine in stroke prevention, aimed at reducing the global stroke burden.

  • Effects of Lifestyle Medicine on Alzheimer’s Disease: Insights From Emerging Evidence and Multi-Domain Interventions

    by Heather Schickedanz, Cyrus Safaeipour, Dean Sherzai, Ayesha Sherzai

    Alzheimer’s Disease (AD) and related dementias, encompassing primarily neurodegenerative but also mixed etiologies, represent a mounting public health concern expected to affect over 15 million Americans by 2060. This review synthesizes emerging evidence on how Lifestyle Medicine can meaningfully reduce risk and slow the progression of dementia. While genetic factors contribute to AD, mounting data highlight the central role that modifiable lifestyle factors, including nutrition, physical activity, sleep hygiene, stress management, social and cognitive engagement, and sensory health, play in its pathogenesis and trajectory. Mediterranean-type diets, regular exercise, robust sleep, stress mitigation, and social connectedness are associated with lower dementia risk, while smoking, excess alcohol, and chronic psychological stress elevate risk. Integrative strategies, such as mindfulness meditation and sensor-based digital monitoring, hold promise for individualized prevention and care. Culturally informed, holistic approaches addressing structural barriers and supporting caregivers are critical for equitable dementia prevention. This review presents compelling evidence that Lifestyle Medicine implemented in tandem with emerging technologies offers a scalable, cost-effective, and patient-centered framework for reducing the impact of AD and related dementias while enhancing well-being among patients, families, and communities.


  • A Systematic Review of Omega-3 Fatty Acid Consumption and Cognitive Outcomes in Neurodevelopment

    by Dean Sherzai, Roman Moness, Sophia Sherzai, Ayesha Sherzai

    Introduction: This systematic review addresses the effects of n-3 long-chain polyunsaturated fatty acids consumption on human neurodevelopment. It evaluates articles published between 2000 and 2022 investigating the cognitive outcomes during the period of neurodevelopment: from fetal development to adolescence. For the purpose of this review the terms LC PUFA and omega-3 fatty acid will be used interchangeably. Method: Data were sourced from several major databases including PubMed (MEDLINE), Web of Science, and ProQuest Central. Randomized controlled trials (RCTs), nonrandomized controlled trials, prospective or retrospective cohort studies, and observational studies investigating the effects of omega-3 fatty acid consumption from dietary supplements, multiple-nutrient supplement, or food questionnaire on neurodevelopment were considered. Study population was separated in three developmental phases: (1) in-utero, (2) lactation/infancy, and (3) childhood/adolescence. Each article was evaluated for several key factors such as study type, type/dosage of PUFAs, number of subjects, length of intervention, participant age range, population characteristics, outcome measure (both primary/cognitive and secondary/other), results, conclusion, and confounding variables/limitations. Results: A total of 88 articles were included in the review, 69 RCTs and 19 longitudinal or observational studies. The results indicate equivocal effect of intervention, with some short-term benefits observed in the areas of visual attention, working memory, executive function, and communication. Omega-3 supplement might have a short-term positive impact on neurodevelopment in all three phases. Supplementation is recommended throughout life, rather than only during the earliest developmental stage.


  • A Systematic Review of Omega-3 Consumption and Neuroprotective Cognitive Outcomes

    by Ayesha Z. Sherzai, Alexander N. Sherzai, Dean Sherzai

    Context: While a great deal of interest has been accorded to the cognitive effects of n-3 long-chain polyunsaturated fatty acids (LC PUFAs), there is a need for systematic review data that assess this outcome across the lifespan, accounting for population differences and highlighting methodological limitations of extant studies. Objective: This systematic review addresses the effects of n-3s on human cognition and provides an overview on the current state of research and recommendations for future efforts. Data Sources: Based on a thorough review of highly powered articles from PubMed (MEDLINE), Web of Science, and ProQuest Central, the authors evaluated articles published between 2000 and 2020 assessing LC PUFA status on cognition as a primary outcome measure. Using the PRISMA guidelines, the researchers’ primary aim was to provide a comprehensive overview of the articles. Conclusions: The results indicate inconsistent effects of intervention, with benefits for specific groups on specific outcomes. Although results were rarely definitive across cognitive domains, and the majority of studies indicated the presence of a possible threshold effect in which LC PUFA needs were already being met, and supplementation did not have an additional effect, there is evidence for trends towards benefit in cognitive functions, in those experiencing early cognitive decline.


  • The INFINITE Study: Pilot Research Exploring Plant-Based Nutrition in Treatment for Substance Use Disorders

    by Tara Kemp, Nanette V. Lopez, Shaun Ward, Dean Sherzai, Ayesha Sherzai, Jay Sutliffe

    Standard treatment for substance use disorders (SUDs) rarely incorporates a dietary intervention. The purpose of this research is to explore how nutrition might influence early recovery outcomes. Participants (N = 33) self-selected into the 10-week treatment (whole food, plant-based diet) or control group (standard treatment center diet). Both received weekly nutrition education lessons to complement the diet. At baseline, week 3, and week 10, participants completed assessments to track mental health markers. Mean values were calculated for Healthy Eating Index-2015 (HEI-2015) and Plant-based Diet Indices (PDI). Semi-structured interviews were gathered and analyzed using grounded theory. The intervention group had significantly higher scores for HEI-2015 and PDI scores (all P ’s < .001). For all psychosocial outcomes, there was a statistically significant effect of time ( P ’s < .001-.02), but not by condition. A significant condition by time interaction was seen with the Rosenberg Self-Esteem outcome ( P = .043). Resilience at 10-weeks was significantly higher in the high PDI group ( P = .031). Qualitative data showed that all participants found meaning and value in the experience. Early addiction treatment outcomes show modest but important effects of whole food plant-based nutrition and suggest value in further exploration of its use in SUD treatment.


  • Open Access

    Retinal Venular Tortuosity Jointly with Retinal Amyloid Burden Correlates with Verbal Memory Loss: A Pilot Study

    by Oana M. Dumitrascu, Ryan Rosenberry, Dale S. Sherman, Maziyar M. Khansari, Julia Sheyn, Tania Torbati, Ayesha Sherzai, Dean Sherzai, Kenneth O. Johnson, Alan D. Czeszynski, et al.

    Introduction: Retinal imaging is a non-invasive tool to study both retinal vasculature and neurodegeneration. In this exploratory retinal curcumin-fluorescence imaging (RFI) study, we sought to determine whether retinal vascular features combined with retinal amyloid burden correlate with the neurocognitive status. Methods: We used quantitative RFI in a cohort of patients with cognitive impairment to automatically compute retinal amyloid burden. Retinal blood vessels were segmented, and the vessel tortuosity index (VTI), inflection index, and branching angle were quantified. We assessed the correlations between retinal vascular and amyloid parameters, and cognitive domain Z-scores using linear regression models. Results: Thirty-four subjects were enrolled and twenty-nine (55% female, mean age 64 ± 6 years) were included in the combined retinal amyloid and vascular analysis. Eleven subjects had normal cognition and 18 had impaired cognition. Retinal VTI was discriminated among cognitive scores. The combined proximal mid-periphery amyloid count and venous VTI index exhibited significant differences between cognitively impaired and cognitively normal subjects (0.49 ± 1.1 vs. 0.91 ± 1.4, p = 0.006), and correlated with both the Wechsler Memory Scale-IV and SF-36 mental component score Z-scores (p < 0.05). Conclusion: This pilot study showed that retinal venular VTI combined with the proximal mid-periphery amyloid count could predict verbal memory loss. Future research is needed to finesse the clinical application of this retinal imaging-based technology.


  • Alzheimer Disease and Cancer

    by Ayesha Z. Sherzai, Melvin Do Parasram, Janelle M. Haider, Dean MD Sherzai

    Introduction: Studies have demonstrated an inverse relationship between Alzheimer dementia (AD) and cancer. This inverse relationship was further explored. In addition, Pin1 expression has been implicated in the cell cycle regulation of both disease processes. The relationship of Pin1 expression in 10 cancer types and secondary diagnosis of AD was examined. Materials and Methods: A cross-sectional analysis was performed using discharge data from the National Inpatient Sample from 1999 to 2008. Cancer was defined as the primary discharge diagnosis and AD was defined as the secondary discharge diagnosis. Cancer types were grouped according to their Pin1 expression to examine its relationship with AD. Analysis was performed by logistic regression. Results: Of ∼3 million cancer discharge diagnoses, 1.0% had a secondary diagnosis of AD. Discharge data of all 10 cancer types revealed a lower likelihood of secondary AD diagnosis. Prostate [crude odds ratios (OR): 0.26 (0.24 to 0.29), multivariate OR: 0.39 (0.35 to 0.43)], ovarian [crude OR: 0.38 (0.32 to 0.44), multivariate OR: 0.35 (0.30 to 0.41)], and lung cancer [crude OR: 0.39 (0.36 to 0.41), multivariate OR: 0.41 (0.39 to 0.44)] demonstrated the lowest odds of secondary AD diagnosis. When cancer types were grouped per Pin1 expression, cancer types with Pin1 underexpression were more likely to be associated with secondary diagnosis of AD than cancer types with Pin1 overexpression [crude OR: 1.4 (1.3 to 1.4), multivariate OR: 1.08 (1.02 to 1.14)]. Discussion: This secondary data analysis further demonstrated an inverse relationship between AD and 10 cancer types, with prostate, ovarian, and lung cancers displaying the greatest inverse relationship. Pin1 underexpressing cancer types had a significantly higher likelihood of secondary diagnosis of AD than Pin1 overexpressing cancer types.